1. Guest, the two part 'News in Brief' for the week beginning 16th May 2022 is here.
    Dismiss Notice
  2. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

A systematic review of nutraceutical interventions for mitochondrial dysfunctions in ME/CFS, 2021, Marshall-Gradisnik et al

Discussion in 'ME/CFS research news' started by John Mac, Feb 18, 2021.

  1. John Mac

    John Mac Senior Member (Voting Rights)

    Hutan, Snowdrop, Andy and 1 other person like this.
  2. Tom Kindlon

    Tom Kindlon Senior Member (Voting Rights)

    Not picked up by the algorithm:
    "Amantadine & L-carnitine treatment of #ChronicFatigueSyndrome" https://pubmed.ncbi.nlm.nih.gov/9018019/
    This used 3000 mg of L-carnitine (a lot of people who try it don't take that dosage)
    This has helped me: particularly noticeable when I stopped it
  3. ME/CFS Skeptic

    ME/CFS Skeptic Senior Member (Voting Rights)

    How come so many ME/CFS papers are published in the Journal of Translational Medicine?
    James Morris-Lent likes this.
  4. Perrier

    Perrier Senior Member (Voting Rights)

    Yes, L Carnitine is very interesting; I do not haveME, but I use 3000-4000mg per day to deal with being in the grey zone on the edge of moving to hyperthyroid. Many years ago an Italian endocrinologist used this method, along with an occasional Ativan 1mg, to deal with folks in the grey zone. I have been doing this for 10 years. But in the case of ME, if there is low thyroid using L carnitine would be a very risky business.
    alktipping and Mij like this.

Share This Page